Does Reduction of Number of Intradetrusor Injection Sites of aboBoNTA (Dysport®) Impact Efficacy and Safety in a Rat Model of Neurogenic Detrusor Overactivity?

about

Does Reduction of Number of Intradetrusor Injection Sites of aboBoNTA (Dysport®) Impact Efficacy and Safety in a Rat Model of Neurogenic Detrusor Overactivity?

Item

http://www.wikidata.org/entity/Q36401506

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Does Reduction of Number of In ...... rogenic Detrusor Overactivity?

@ast

Does Reduction of Number of In ...... rogenic Detrusor Overactivity?

@en

type

Item

label

Does Reduction of Number of In ...... rogenic Detrusor Overactivity?

@ast

Does Reduction of Number of In ...... rogenic Detrusor Overactivity?

@en

prefLabel

Does Reduction of Number of In ...... rogenic Detrusor Overactivity?

@ast

Does Reduction of Number of In ...... rogenic Detrusor Overactivity?

@en

P1476

Does Reduction of Number of In ...... rogenic Detrusor Overactivity?

@en

P2093

Amélie Huynh Le Maux

http://www.w3.org/2001/XMLSchema#string

Bernadette Pignol

http://www.w3.org/2001/XMLSchema#string

Delphine Behr-Roussel

http://www.w3.org/2001/XMLSchema#string

François Giuliano

http://www.w3.org/2001/XMLSchema#string

Jacques Bernabé

http://www.w3.org/2001/XMLSchema#string

Jean-Luc Blachon

http://www.w3.org/2001/XMLSchema#string

Philippe Picaut

http://www.w3.org/2001/XMLSchema#string

Pierre Denys

http://www.w3.org/2001/XMLSchema#string

Pierre-Etienne Chabrier

http://www.w3.org/2001/XMLSchema#string

Sandrine Compagnie

http://www.w3.org/2001/XMLSchema#string

P2860

Use of botulinum toxin in individuals with neurogenic detrusor overactivity: state of the art review

Contemporary management of lower urinary tract disease with botulinum toxin A: a systematic review of botox (onabotulinumtoxinA) and dysport (abobotulinumtoxinA).

Adverse events after botulinum A toxin injection for neurogenic voiding disorders.

Proposed mechanism for the efficacy of injected botulinum toxin in the treatment of human detrusor overactivity.

Botulinum toxin type A normalizes alterations in urothelial ATP and NO release induced by chronic spinal cord injury.

Botulinum toxin A (Botox) intradetrusor injections in adults with neurogenic detrusor overactivity/neurogenic overactive bladder: a systematic literature review.

Comparison of the effects of complete and incomplete spinal cord injury on lower urinary tract function as evaluated in unanesthetized rats.

Researching bladder afferents-determining the effects of β(3) -adrenergic receptor agonists and botulinum toxin type-A.

Targets for botulinum toxin in the lower urinary tract.

Diffusion, spread, and migration of botulinum toxin.

P304

5462-5471

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3390/TOXINS7124896

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-12-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

289202364

http://www.w3.org/2001/XMLSchema#string

P698

26694464

http://www.w3.org/2001/XMLSchema#string

P932

4690145

http://www.w3.org/2001/XMLSchema#string